Characterization of a novel multifunctional resveratrol derivative for the treatment of atrial fibrillation

Application of free radical diphenylpicrylhydrazyl (DPPH) to estimate the antioxidant capacity of food samples

(2013) Krystyna Pyrzynska et al.   Analytical Methods

The Concise Guide to PHARMACOLOGY 2013/14: Overview

(2013) Stephen P.H. Alexander et al.   BRITISH JOURNAL OF PHARMACOLOGY

Role of Late Sodium Channel Current Block in the Management of Atrial Fibrillation

(2012) Alexander Burashnikov et al.   CARDIOVASCULAR DRUGS AND THERAPY

An Update on the Prognosis of Patients With Atrial Fibrillation

(2012) David D. McManus et al.   CIRCULATION

Resveratrol: A Natural Polyphenol with Multiple Chemopreventive Properties (Review)

(2012) Fabrizia Brisdelli et al.   CURRENT DRUG METABOLISM

2012 focused update of the ESC Guidelines for the management of atrial fibrillation

(2012) et al.   EUROPEAN HEART JOURNAL

Novel molecular targets for atrial fibrillation therapy

(2012) Dobromir Dobrev et al.   NATURE REVIEWS DRUG DISCOVERY

Resveratrol as a calorie restriction mimetic: therapeutic implications

(2012) Jay H. Chung et al.   TRENDS IN CELL BIOLOGY

Resveratrol: a cardioprotective substance

(2011) Joseph M. Wu et al.   Annals of the New York Academy of Sciences

Calorie restriction and resveratrol in cardiovascular health and disease

(2011) Vernon W. Dolinsky et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

Ultra-rapid delayed rectifier channels: molecular basis and therapeutic implications

(2011) U. Ravens et al.   CARDIOVASCULAR RESEARCH

Dronedarone in High-Risk Permanent Atrial Fibrillation

(2011) Stuart J. Connolly et al.   NEW ENGLAND JOURNAL OF MEDICINE

Novel pharmacological targets for the rhythm control management of atrial fibrillation

(2011) Alexander Burashnikov et al.   PHARMACOLOGY & THERAPEUTICS

Guidelines for reporting experiments involving animals: the ARRIVE guidelines

(2010) JC McGrath et al.   BRITISH JOURNAL OF PHARMACOLOGY

Animal research: Reporting in vivo experiments: The ARRIVE guidelines

(2010) Carol Kilkenny et al.   BRITISH JOURNAL OF PHARMACOLOGY

In Humans, Chronic Atrial Fibrillation Decreases the Transient Outward Current and Ultrarapid Component of the Delayed Rectifier Current Differentially on Each Atria and Increases the Slow Component of the Delayed Rectifier Current in Both

(2010) Ricardo Caballero et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

New antiarrhythmic drugs for treatment of atrial fibrillation

(2010) Dobromir Dobrev et al.   LANCET

Increasing Prevalence of Atrial Fibrillation and Flutter in the United States

(2009) Gerald V. Naccarelli et al.   AMERICAN JOURNAL OF CARDIOLOGY

Atrial Fibrillation and Heart Failure

(2009) Elad Anter et al.   CIRCULATION

Resveratrol Prevents the Prohypertrophic Effects of Oxidative Stress on LKB1

(2009) Vernon W. Dolinsky et al.   CIRCULATION

IKur/Kv1.5 channel blockers for the treatment of atrial fibrillation

(2009) Juan Tamargo et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Atrial-selective pharmacological therapy for atrial fibrillation: hype or hope?

(2008) Joachim R Ehrlich et al.   CURRENT OPINION IN CARDIOLOGY

Resveratrol Inhibits Cardiac Hypertrophy via AMP-activated Protein Kinase and Akt

(2008) Anita Y. M. Chan et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

New Drugs Targeting the Cardiac Ultra-Rapid Delayed-Rectifier Current (IKur): Rationale, Pharmacology and Evidence for Potential Therapeutic Value

(2008) John W Ford et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY